anti-hiv-agents

Documents about anti-hiv-agents

• HIV drug resistance: tackling HIV drug resistance: trends, guidelines and global actions: policy brief#466860WHO IRIS
• Report on the global action plan on HIV drug resistance 2017–2021#466859WHO IRIS
• T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents#1211990ClinicalTrials.gov
• Integrating HIV prevention into practice#221522UNSWorks Repository
• Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030#151807WHO IRIS
• HIV and Ovarian Reserve#848334ClinicalTrials.gov
• Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations#1371743ClinicalTrials.gov
• Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel#1484377ClinicalTrials.gov
• The Mochudi Prevention Project ART Protocol#886999ClinicalTrials.gov
• Switch to Unboosted Atazanavir With Tenofovir Study#1336727ClinicalTrials.gov
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients#811365ClinicalTrials.gov
• Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients#813103ClinicalTrials.gov
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs#810911ClinicalTrials.gov
• Outcomes of Anti-HIV Therapy During Early HIV Infection#826463ClinicalTrials.gov
• A Study to Compare Two Anti-HIV Drug Combinations#915018ClinicalTrials.gov
• Safety and Effectiveness of a Combination Anti-HIV Drug Treatment#847826ClinicalTrials.gov
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients#1138563ClinicalTrials.gov
• Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring#837042ClinicalTrials.gov
• Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV#1138257ClinicalTrials.gov
• A Study to Compare Two Different Anti-HIV Drug Regimens#854656ClinicalTrials.gov
• The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs#1243066ClinicalTrials.gov
• A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)#1102524ClinicalTrials.gov
• T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs#894010ClinicalTrials.gov
• A Study of Amprenavir in HIV-Infected Patients#1369852ClinicalTrials.gov
• A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations#1009201ClinicalTrials.gov
• Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis Regimens#1408248ClinicalTrials.gov
• Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations#836125ClinicalTrials.gov
• The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients#903227ClinicalTrials.gov
• HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs#1418559ClinicalTrials.gov
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection#1486688ClinicalTrials.gov
• Viracept Expanded Access Program#804039ClinicalTrials.gov
• A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment#1102460ClinicalTrials.gov
• Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients#1383156ClinicalTrials.gov
• The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs#1058720ClinicalTrials.gov
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women#827312ClinicalTrials.gov
• A Safety Study of Dapivirine Vaginal Ring in Africa#1477087ClinicalTrials.gov
• Safety, PK, and PD Study of IVRs Releasing TFV and LNG#1429564ClinicalTrials.gov
• The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients#898316ClinicalTrials.gov
• A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients#1362144ClinicalTrials.gov
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children#1408624ClinicalTrials.gov
• A Study of Two Anti-HIV Drug Combinations#1485038ClinicalTrials.gov
• Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)#1214623ClinicalTrials.gov
• A Study of Viracept in HIV-Positive Women#1464359ClinicalTrials.gov
• Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs#1431563ClinicalTrials.gov
• Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs#901545ClinicalTrials.gov
• The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients#1230186ClinicalTrials.gov
• A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients#1487341ClinicalTrials.gov
• A Study of MKC-442 in Combination With Other Anti-HIV Drugs#1282160ClinicalTrials.gov
• The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#863314ClinicalTrials.gov
• A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#1384470ClinicalTrials.gov